A, B, C, D) (150 QUESTIONS) UP-TO-DATE ACTUAL EXAM
QUESTIONS AND 100% ACCURATE SOLUTIONS |
VERIFIED ANSWERS - INSTANT PDF DOWNLOAD
Examiner/Administrator: Kaplan Nursing
Candidate Name: ______________________________________
Candidate ID: ________________________________________
Date: ________________________________________________
Examination Centre: __________________________________
Time Allowed: 180 Minutes
Total Questions: 150
Instructions: Answer all questions. Select the best possible answer for each question.
_This integrated pharmacology examination assesses a candidate’s ability to apply
pharmacological principles in clinical nursing and medical contexts. The exam evaluates
knowledge across drug classifications, mechanisms of action, therapeutic uses, adverse
effects, contraindications, and patient safety considerations. Candidates are expected to
demonstrate clinical reasoning, prioritization, and safe medication administration practices
aligned with current evidence-based standards._
Core Competency Areas:
• Pharmacokinetics and Pharmacodynamics
• Cardiovascular and Renal Pharmacology
• Neurological and Psychiatric Medications
• Endocrine and Metabolic Agents
• Anti-infective Therapies
• Pain Management and Anesthesia
• Patient Safety and Medication Administration
_Candidates must carefully read each question and select the most appropriate answer.
Calculators are permitted for dosage calculations. No external reference materials are
allowed. Time management is critical; allocate approximately one minute per question.
Ensure all responses are recorded clearly. This exam contains approximately 150 questions
designed to reflect the rigor of professional pharmacology assessments._
, Disclaimer: This is a simulated examination created for educational purposes and is not
affiliated with or extracted from any official Kaplan examination.
Q1. A 68-year-old patient with chronic heart failure is prescribed digoxin. The
nurse notes the patient has hypokalemia. What is the most critical concern
regarding this finding?
A. Reduced drug efficacy
B. Increased risk of digoxin toxicity
C. Increased renal clearance of digoxin
D. Development of hypernatremia
Correct Answer: B. Increased risk of digoxin toxicity
Explanation: 🟡 Hypokalemia enhances digoxin binding to Na+/K+ ATPase,
increasing toxicity risk. Option A is incorrect because efficacy may actually
increase. Option C is incorrect as renal clearance is unrelated to potassium
levels. Option D is unrelated to digoxin pharmacology.
Q2. A patient receiving IV vancomycin develops flushing and hypotension.
What is the most likely cause?
A. IgE-mediated allergy
B. Red man syndrome due to rapid infusion
C. Drug-induced nephrotoxicity
D. Anaphylactic shock
Correct Answer: B. Red man syndrome due to rapid infusion
Explanation: 🟡 Rapid vancomycin infusion causes histamine release leading to
flushing. Option A is incorrect as this is not a true allergy. Option C refers to
,kidney damage, not acute flushing. Option D is more severe and involves
airway compromise.
Q3. A patient on warfarin therapy starts taking aspirin independently. What is
the primary risk?
A. Decreased anticoagulation
B. Increased clot formation
C. Increased bleeding risk
D. Reduced platelet aggregation
Correct Answer: C. Increased bleeding risk
Explanation: 🟡 Both drugs impair clotting—warfarin affects clotting factors,
aspirin inhibits platelets—raising bleeding risk. Option A is incorrect as
anticoagulation increases. Option B is opposite effect. Option D contributes to
bleeding but is not the overall risk outcome.
Q4. Which pharmacokinetic phase involves drug metabolism primarily in the
liver?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: C. Metabolism
Explanation: 🟡 Metabolism (biotransformation) occurs mainly in the liver via
CYP enzymes. Other options refer to different pharmacokinetic phases.
, Q5. A nurse administers morphine and observes respiratory depression. Which
receptor is primarily responsible?
A. Alpha-1 receptor
B. Mu-opioid receptor
C. Beta-2 receptor
D. Dopamine receptor
Correct Answer: B. Mu-opioid receptor
Explanation: 🟡 Mu receptors mediate analgesia and respiratory depression.
Other receptors are unrelated to opioid effects.
Q6. A patient with asthma is prescribed propranolol. What is the concern?
A. Hypertension
B. Bronchoconstriction
C. Hyperglycemia
D. Renal failure
Correct Answer: B. Bronchoconstriction
Explanation: 🟡 Propranolol blocks beta-2 receptors causing
bronchoconstriction. Other options are not the primary concern.
Q7. Which drug class is contraindicated in pregnancy due to teratogenicity?
A. ACE inhibitors
B. Beta blockers
C. Calcium channel blockers
D. Antacids
Correct Answer: A. ACE inhibitors